Last update at 2025-03-13T20:00:00Z
American Healthcare REIT (AHR) Matches Q4 FFO Estimates
Thu 27 Feb 25, 11:20 PMAmerican Healthcare REIT Among 3 Stocks Valued Below Intrinsic Estimates
Thu 27 Feb 25, 05:08 PMChatham Lodging (CLDT) Q4 FFO and Revenues Top Estimates
Wed 26 Feb 25, 12:40 PMEasterly Government Properties (DEA) Q4 FFO and Revenues Lag Estimates
Tue 25 Feb 25, 12:40 PMJanuary 2025 US Stocks Estimated To Be Trading Below Fair Value
Wed 29 Jan 25, 10:02 AM2 Healthcare REIT Stocks to Buy Before Moving Into 2025
Tue 24 Dec 24, 02:37 PMThe comeback of REITs: Top ways to play commercial real estate
Sun 22 Dec 24, 03:00 PM| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -76.22400M | 261.64M | 179.29M | 187.49M | -18.85900M |
| Minority interest | 5.42M | -7.91900M | 5.47M | -6.70000M | - |
| Net income | -71.46900M | -72.79700M | -52.31300M | 5.79M | -18.76900M |
| Selling general administrative | 47.51M | 43.42M | 43.20M | 27.01M | 29.75M |
| Selling and marketing expenses | 57.48M | - | - | 27.01M | - |
| Gross profit | 293.56M | -145.91000M | 81.10M | 119.54M | 18.48M |
| Reconciled depreciation | 237.30M | 200.60M | 157.38M | 129.65M | - |
| Ebit | 86.97M | -1519.37100M | -1051.10400M | -949.08600M | -1.13600M |
| Ebitda | 324.26M | 315.23M | 186.00M | 206.71M | 44.49M |
| Depreciation and amortization | 237.30M | 1834.60M | 1237.11M | 1155.80M | 45.63M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 244.34M | 450.47M | 133.19M | 98.86M | -1.13600M |
| Other operating expenses | 1613.09M | 1526.91M | 1228.36M | 1096.71M | 121.91M |
| Interest expense | 163.19M | 105.96M | 80.94M | 71.28M | - |
| Tax provision | 0.66M | 0.59M | 0.96M | -3.07800M | - |
| Interest income | - | - | - | - | - |
| Net interest income | -163.19100M | -105.95600M | -80.93700M | -71.27800M | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.66M | -188.82800M | 46.10M | 88.63M | -0.00800M |
| Total revenue | 1859.14M | 1645.77M | 1283.21M | 1244.42M | 120.77M |
| Total operating expenses | 47.51M | 185.70M | 159.44M | 70.68M | 140.07M |
| Cost of revenue | 1565.58M | 1791.68M | 1202.11M | 1124.88M | 102.29M |
| Total other income expense net | -320.55900M | -163.38700M | -191.12200M | -125.78600M | -17.72300M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -76.88700M | -73.38300M | -53.26900M | 8.86M | - |
| Net income applicable to common shares | - | - | - | - | - |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 4577.93M | 539.22M | 1062.62M | 3234.94M | 1068.33M |
| Intangible assets | 180.47M | 236.28M | 248.87M | 154.69M | 160.25M |
| Earning assets | - | - | - | - | - |
| Other current assets | -0.20300M | -0.01300M | 2.83M | 55.60M | -28.47200M |
| Total liab | 3118.76M | 0.66M | 2.62M | 2160.11M | 476.79M |
| Total stockholder equity | 1270.32M | 4786.70M | 4580.34M | 866.11M | 590.08M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 529.43M | 965.06M | 305.60M | 126.85M | 883.02M |
| Common stock | 0.66M | 0.66M | 0.66M | 1.80M | 0.80M |
| Capital stock | 0.66M | 0.66M | 0.66M | - | - |
| Retained earnings | -1276.22200M | 1400.09M | 1581.29M | -864.27100M | -130.61300M |
| Other liab | - | - | - | - | - |
| Good will | 234.94M | 231.61M | 209.90M | 75.31M | 75.31M |
| Other assets | 80.74M | -4247.47400M | -3517.72200M | - | -2103.96200M |
| Cash | 43.45M | 111.91M | 125.49M | 152.19M | 15.85M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1466.87M | 16.30M | 21.16M | 194.68M | 173.72M |
| Current deferred revenue | -565.71600M | -5366.68000M | -4191.50800M | -3862.34900M | -779.82500M |
| Net debt | 2975.68M | -47.04800M | -67.95300M | 1724.71M | 420.08M |
| Short term debt | 846.77M | 316.73M | 921.90M | 1654.11M | 8.32M |
| Short long term debt | 1223.97M | 1281.79M | 1226.63M | - | - |
| Short long term debt total | 3019.12M | 64.86M | 57.53M | 1876.90M | 435.93M |
| Other stockholder equity | 2548.31M | 2540.42M | 2533.90M | 1730.59M | 722.15M |
| Property plant equipment | - | - | - | - | - |
| Total current assets | 297.10M | 269.18M | 267.19M | 356.95M | 331.44M |
| Long term investments | 107.55M | 92.58M | 94.93M | - | - |
| Net tangible assets | - | - | - | - | - |
| Short term investments | 1.46M | - | - | - | - |
| Net receivables | 232.92M | 184.37M | 163.84M | 163.47M | 12.63M |
| Long term debt | 1344.15M | 1278.25M | 1129.25M | - | - |
| Inventory | 19.47M | 19.77M | 18.93M | 24.67M | 23.87M |
| Accounts payable | 90.67M | 243.83M | 187.25M | 67.83M | 62.20M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -2.42500M | 1649.36M | 1829.57M | -2.00800M | -2.25500M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 3449.29M | -1105.99800M | -979.04900M | -883.25500M | 1429.82M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 4200.09M | 4517.52M | 4313.15M | 2877.99M | 2840.85M |
| Capital lease obligations | 225.50M | 273.07M | 145.49M | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | 9.40M | -118.57800M | -138.65200M | -147.94500M | - |
| Change to liabilities | - | - | - | - | - |
| Total cashflows from investing activities | - | - | - | - | - |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | -129.06200M | -37.74100M | 102.81M | -19.71100M | 161.59M |
| Change to operating activities | - | - | - | - | - |
| Net income | -71.46900M | -81.30200M | -47.79400M | 2.16M | -18.76900M |
| Change in cash | -21.12400M | -13.58000M | -26.70400M | 136.34M | 1.26M |
| Begin period cash flow | 111.91M | 125.49M | 152.19M | 15.85M | 14.59M |
| End period cash flow | 90.78M | 111.91M | 125.49M | 152.19M | 15.85M |
| Total cash from operating activities | 98.53M | 147.77M | 15.20M | 210.12M | 40.83M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 182.60M | 450.47M | 133.19M | 98.86M | 45.63M |
| Other cashflows from investing activities | - | - | - | - | - |
| Dividends paid | 76.28M | 51.12M | 22.79M | 27.00M | 20.91M |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | -34.72400M | -4.45700M | 3.69M | 20.32M | 3.49M |
| Sale purchase of stock | -0.46900M | -20.69900M | -0.38200M | -23.10700M | -8.60900M |
| Other cashflows from financing activities | -34.72300M | -28.74600M | -20.33900M | -0.72400M | -0.15100M |
| Change to netincome | - | - | - | - | - |
| Capital expenditures | 99.79M | 71.52M | 79.69M | 128.30M | 6.50M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -55.79000M | -37.79800M | -93.46700M | 74.19M | 6.63M |
| Stock based compensation | 5.47M | 3.91M | 9.66M | -1.18700M | 2.96M |
| Other non cash items | 37.72M | 707.92M | 325.68M | 176.85M | 91.88M |
| Free cash flow | -1.25600M | 76.25M | -64.49200M | 81.82M | 34.34M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AHR American Healthcare REIT, Inc. |
0.29 1.01% | 28.89 | - | - | 2.15 | 1.98 | 3.18 | 19.84 |
| WELL Welltower Inc |
-1.49 1.01% | 145.89 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
| VTR Ventas Inc |
0.01 0.02% | 66.36 | 2524.00 | 25.51 | 4.47 | 1.98 | 7.44 | 17.76 |
| OHI Omega Healthcare Investors Inc |
0.19 0.52% | 36.77 | 31.33 | 10.13 | 9.06 | 2.05 | 14.35 | 15.26 |
| HR Healthcare Realty Trust Incorporated |
-0.01 0.06% | 16.31 | - | 10.83 | 4.82 | 0.93 | 8.92 | 15.95 |
American Healthcare REIT, Inc. is a self-managed real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities and other healthcare-related facilities. Its properties are located in 36 states, the United Kingdom and the Isle of Man.
18191 Von Karman Avenue, Irvine, CA, United States, 92612-7106
| Name | Title | Year Born |
|---|---|---|
| Mr. Danny Prosky | President, CEO & Director | 1964 |
| Mr. Brian S. Peay | Chief Financial Officer | 1966 |
| Mr. Gabriel M. Willhite | Chief Operating Officer | 1982 |
| Mr. Stefan K. L. Oh | Chief Investment Officer | 1971 |
| Mr. Mark E. Foster | Executive VP, General Counsel & Secretary | 1974 |
| Mr. Kenny Lin | Executive VP, Deputy CFO & Chief Accounting Officer | 1978 |
| Mr. Alan Robert Peterson III | Vice President of Investor Relations & Finance | NA |
| Ms. Cora Lo Esq., J.D. | Senior VP, Associate General Counsel & Assistant Secretary | 1975 |
| Ms. Wendie Newman | Executive Vice President of Asset Management | 1964 |
| Mr. Ray Oborn | Executive Vice President of Asset Management | 1971 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
US 
AU
UK
CA
NZ
Please wait processing your request...